Biocartis appoints new CEO
This article was originally published in Clinica
Swiss molecular diagnostics company Biocartis has appointed Nayan Gregory Parekh CEO. He replaces current head and company co-founder Rudi Pauwels, who will become executive chairman and focus on the firm's scientific and technology strategy. Dr Parekh has been an executive director on Biocartis's board since April. His experience is mainly in financing and investment; Dr Parekh was most recently at New Rhein Healthcare, an investment firm which he co-founded. Prior to this, he spent six years as head of corporate development at Novartis, where he led the company's investments across different product areas and in various emerging markets.